Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease

Ralf E. Harskamp; Zhe Zheng; John H. Alexander; Judson B. Williams; Ying Xian; Michael E. Halkos; J. Matthew Brennan; Robbert J. De Winter; Peter K. Smith; Renato D. Lopes

doi:10.1016/j.athoracsur.2013.07.093

Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease

Ralf E. Harskamp, Zhe Zheng, John H. Alexander, Judson B. Williams, Ying Xian, Michael E. Halkos, J. Matthew Brennan, Robbert J. De Winter, Peter K. Smith, Renato D. Lopes

Research output: Contribution to journal › Review article › peer-review

40 Scopus citations

Abstract

Hybrid coronary revascularization (HCR) combines bypass grafting of the left anterior descending (LAD) coronary artery with percutaneous coronary intervention (PCI) of non-LAD vessels. HCR has been performed as an alternative to CABG or multi-vessel PCI in thousands of patients since the late 1990s. In this review article, we provide an overview on patient selection, procedural sequence and timing, use of surgical techniques and anti-platelet agents. Additionally, patient recovery, satisfaction, costs and clinical outcomes of individual studies after HCR are evaluated. Future directions are also discussed, including the need for adequately powered randomized trials.

Original language	English (US)
Pages (from-to)	2268-2277
Number of pages	10
Journal	Annals of Thoracic Surgery
Volume	96
Issue number	6
DOIs	https://doi.org/10.1016/j.athoracsur.2013.07.093
State	Published - Dec 2013
Externally published	Yes

ASJC Scopus subject areas

Surgery
Pulmonary and Respiratory Medicine
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.athoracsur.2013.07.093

Cite this

@article{e1e591ce2d844d8797414f9d62deb1cd,

title = "Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease",

abstract = "Hybrid coronary revascularization (HCR) combines bypass grafting of the left anterior descending (LAD) coronary artery with percutaneous coronary intervention (PCI) of non-LAD vessels. HCR has been performed as an alternative to CABG or multi-vessel PCI in thousands of patients since the late 1990s. In this review article, we provide an overview on patient selection, procedural sequence and timing, use of surgical techniques and anti-platelet agents. Additionally, patient recovery, satisfaction, costs and clinical outcomes of individual studies after HCR are evaluated. Future directions are also discussed, including the need for adequately powered randomized trials.",

author = "Harskamp, {Ralf E.} and Zhe Zheng and Alexander, {John H.} and Williams, {Judson B.} and Ying Xian and Halkos, {Michael E.} and Brennan, {J. Matthew} and {De Winter}, {Robbert J.} and Smith, {Peter K.} and Lopes, {Renato D.}",

year = "2013",

month = dec,

doi = "10.1016/j.athoracsur.2013.07.093",

language = "English (US)",

volume = "96",

pages = "2268--2277",

journal = "Annals of Thoracic Surgery",

issn = "0003-4975",

publisher = "Elsevier USA",

number = "6",

}

TY - JOUR

T1 - Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease

AU - Harskamp, Ralf E.

AU - Zheng, Zhe

AU - Alexander, John H.

AU - Williams, Judson B.

AU - Xian, Ying

AU - Halkos, Michael E.

AU - Brennan, J. Matthew

AU - De Winter, Robbert J.

AU - Smith, Peter K.

AU - Lopes, Renato D.

PY - 2013/12

Y1 - 2013/12

N2 - Hybrid coronary revascularization (HCR) combines bypass grafting of the left anterior descending (LAD) coronary artery with percutaneous coronary intervention (PCI) of non-LAD vessels. HCR has been performed as an alternative to CABG or multi-vessel PCI in thousands of patients since the late 1990s. In this review article, we provide an overview on patient selection, procedural sequence and timing, use of surgical techniques and anti-platelet agents. Additionally, patient recovery, satisfaction, costs and clinical outcomes of individual studies after HCR are evaluated. Future directions are also discussed, including the need for adequately powered randomized trials.

AB - Hybrid coronary revascularization (HCR) combines bypass grafting of the left anterior descending (LAD) coronary artery with percutaneous coronary intervention (PCI) of non-LAD vessels. HCR has been performed as an alternative to CABG or multi-vessel PCI in thousands of patients since the late 1990s. In this review article, we provide an overview on patient selection, procedural sequence and timing, use of surgical techniques and anti-platelet agents. Additionally, patient recovery, satisfaction, costs and clinical outcomes of individual studies after HCR are evaluated. Future directions are also discussed, including the need for adequately powered randomized trials.

UR - http://www.scopus.com/inward/record.url?scp=84889240238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889240238&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2013.07.093

DO - 10.1016/j.athoracsur.2013.07.093

M3 - Review article

C2 - 24446561

AN - SCOPUS:84889240238

SN - 0003-4975

VL - 96

SP - 2268

EP - 2277

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

IS - 6

ER -

Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this